Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes
Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes
批准号:
8177528
负责人:
JIN-HONG CHANG
金额:
$23.86万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2013-07-31
关键词:
AffectAlkaliesBindingBiosensorBlindnessBurn injuryCell ProliferationCellsCorneaCorneal DiseasesCorneal InjuryDataDevelopmentDimerizationDiseaseDoseDown-RegulationEndostatinsEquilibriumEventFibroblast Growth Factor 2Fluorescence Resonance Energy TransferGoalsHeterodimerizationHomodimerizationHumanIn VitroInfectionInvestigationLungLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphatic SystemLymphatic vesselMeasuresMethodsMolecularPathologicPathologyPeptidesPhosphorylationPhosphotransferasesPhysiologicalPlayProcessProductionRegulationRoleSignal TransductionTestingVascular Endothelial Growth Factor CVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3Vascular Endothelial Growth FactorsWound Infectionangiogenesisbaseconjunctivacorneal epitheliumdesignin vivoinhibitor/antagonistnovelnovel therapeutic interventionocular surfacereceptorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Corneal lymphangiogenesis follows severe corneal injuries and infections and is one of the major causes of blindness. Under normal physiological conditions, the cornea is alymphatic and surrounded by lymphatic vessels residing in the conjunctiva while corneal lymphangiogenic privilege is maintained. However, wounding and infection induce corneal lymphangiogenesis. The extrinsic factors that regulate corneal lymphangiogenic privilege include: 1) the presence of angiogenic and lymphangiogenic factors (VEGF-A, -C and -D); 2) expression of sVEGFR-2 in the cornea; 3) expression of VEGFR-3 in corneal epithelium and other anti-lymphangiogenic factors in the cornea. The status of corneal lymphangiogenesis is controlled by the balance of pro- and anti- lymphatic factors. The current hypothesis of corneal lymphangiogenic privilege is governed by extrinsic factors unique to the cornea. Besides the well-documented extrinsic factors involved in regulating corneal lymphangiogenic privilege, changes in the VEGFR-2 may regulate VEGFR3-activation in lymphatic cells also regulate corneal lymphangiogenesis. Our preliminary data demonstrated corneal lymphangiogenesis in diseased human corneas, which correlated with enhanced VEGFR-3 expression in alkali-burn-wounded corneas. In addition, endostatin-containing fragments bind to VEGFR-3 in vitro and have better inhibition of bFGF-induced corneal lymphangiogenesis than angiogenesis. VEGF- C-induced VEGFR-3 dimerization and low dose VEGF-C has better potency in promoting lymphatic cell proliferation. Our long-term objective is to identify the mechanisms that regulate corneal lymphangiogenesis. The proposed experiments are designed to determine the role of VEGF-C-induced VEGFR-3 homodimerization regulated by VEGF-2/-3 heterodimerization and to investigate selective inhibitors for the inhibition of VEGFR-3 homodimerization during corneal lymphangiogenesis.
PUBLIC HEALTH RELEVANCE: Lymphangiogenesis is the process of increased production of lymphatic vessels and can be both physiological and pathological. We hypothesize that VEGFR-2 interferes with VEGFR-3 dimerization may play a role in the regulation of corneal lymphangiogenesis. Understanding the molecular mechanisms of corneal lymphangiogenesis will provide novel therapeutic interventions in the treatment of lymphangiogenesis-related disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection
-
批准号:10683941
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JIN-HONG CHANG
-
依托单位:
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection
-
批准号:10155431
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JIN-HONG CHANG
-
依托单位:
Modulation of VEGF receptors to prevent limbal stem cell transplant rejection
-
批准号:10455420
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:JIN-HONG CHANG
-
依托单位:
Endostatin-derived Short Peptides in Corneal Transplantation
-
批准号:8811330
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JIN-HONG CHANG
-
依托单位:
Endostatin-derived Short Peptides in Corneal Transplantation
-
批准号:8627925
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JIN-HONG CHANG
-
依托单位:
Endostatin-derived Short Peptides in Corneal Transplantation
-
批准号:9280824
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JIN-HONG CHANG
-
依托单位:
VEGFR2 Modulates Corneal Angiogenesis and Lymphangiogenesis
-
批准号:8569510
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2013
-
负责人:JIN-HONG CHANG
-
依托单位:
VEGFR2 Modulates Corneal Angiogenesis and Lymphangiogenesis
-
批准号:8702186
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2013
-
负责人:JIN-HONG CHANG
-
依托单位:
Inhibition of VEGF receptor dimerization and signaling in corneal lymphangiogenes
-
批准号:8309043
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2011
-
负责人:JIN-HONG CHANG
-
依托单位:
Collagen XVIII in Corneal Neovascularization
-
批准号:7105535
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2003
-
负责人:JIN-HONG CHANG
-
依托单位:
Collagen XVIII in Corneal Neovascularization
-
批准号:6682512
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2003
-
负责人:JIN-HONG CHANG
-
依托单位:
Collagen XVIII in Corneal Neovascularization
-
批准号:6929768
-
项目类别:
-
资助金额:$11.04万
-
财政年份:2003
-
负责人:JIN-HONG CHANG
-
依托单位:
Collagen XVIII in Corneal Neovascularization
-
批准号:7239024
-
项目类别:
-
资助金额:$14.86万
-
财政年份:2003
-
负责人:JIN-HONG CHANG
-
依托单位:
Collagen XVIII in Corneal Neovascularization
-
批准号:6778202
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2003
-
负责人:JIN-HONG CHANG
-
依托单位:
海外基金